Atlas Trials

Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)

Clinical trial NCT00813709 · COMPLETED

Trial details

NCT number
NCT00813709
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple SclerosisClinically Isolated Syndrome
Start date
2008-12-01
Primary completion
2011-08-01
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.